Recent Updates
Recently added Catalysts
GANX Positive Sentiment

New Parkinson’s Biomarker NfL: What You Should Know

Key Takeaway: Neurofilament light chain (NfL) is a protein that indicates neuronal cell death. Elevated NfL levels in blood and brain fluid are linked to severe symptoms and cognitive decline in Parkinson's disease. NfL is being investigated as a biomarker for various neurodegenerative diseases and is being considered in drug approval processes.
Price reaction · baseline $3.52 (2023-08-25 close) · hit pre-market · clean, no other GANX news in the window
day 0 close · peak
-2%

Market Sentiment Analysis

POSITIVE FACTORS

  • NfL shows promise as a biomarker for neurodegenerative diseases.
  • High NfL levels correlate with disease severity and cognitive decline.
  • NfL is being integrated into the drug approval process.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+62%
120-day peak, hindsight
Typical move
7.1%
average across 11 past catalysts
Cash runway
~8 mo
High dilution risk
Lead asset
Low Dose GT-02287
Phase 2 · Parkinson Disease

Full Press Release Details

Neurofilament light chain (NfL) is a protein found inside neurons in the brain. If axons die, for example, due to disease, NfL is released from the brain and can be measured in blood. Thus, rising levels of NfL in the blood may suggest increasing levels of neuronal cell death associated with neurological conditions.
In the early phase of Parkinson’s disease, high levels of NfL in brain fluid are associated with more severe motor symptoms and shorter survival. Those with elevated blood NfL levels also had worse cognitive decline, brain atrophy & motor score.
NfL is being explored as a biomarker in multiple neurodegenerative conditions such as Parkinson’s and Alzheimer’s disease, as well as stroke, multiple sclerosis and traumatic brain injury. It is also being incorporated into the drug approval process.
To get more insights, read our LinkedIn post.

Frequently Asked Questions

What is neurofilament light chain (NfL)?

NfL is a protein found in neurons that indicates neuronal cell death when released into the blood.

How is NfL related to Parkinson's disease?

High NfL levels in brain fluid correlate with severe symptoms and cognitive decline in Parkinson's patients.

What conditions is NfL being studied for?

NfL is being explored as a biomarker for Parkinson's, Alzheimer's, stroke, and multiple sclerosis.

Is NfL used in drug approval processes?

Yes, NfL is being incorporated into the drug approval process for neurodegenerative diseases.

Last updated: Aug 28, 2023